In a significant development in the ongoing trial concerning the safety of formula products for premature infants, a St. Louis City Circuit Court judge has barred a prominent litigator from Kirkland & Ellis, James Hurst, from presenting further arguments on behalf of Abbott Laboratories. Hurst, known for his extensive representation of Abbott, was sanctioned by Judge Michael Noble for what was labeled as “bad faith” conduct during the trial proceedings. The court’s decision follows accusations that Hurst “repeatedly toed the line of appropriate conduct,” which was perceived as an attempt to provoke a mistrial.
The litigation involves Abbott Laboratories and Mead Johnson, both defending against allegations that their formula products contributed to a condition known as necrotizing enterocolitis (NEC) in premature babies. St. Louis Children’s Hospital is also named as a defendant in this case. The court’s sanctions against Hurst are part of an October 24 order, which marks a pivotal moment in the trial.
This case has garnered considerable attention due to the grave medical implications of NEC and the high-profile nature of the defendants involved. The decision to bar Hurst from further participation underscores the seriousness with which the court is approaching procedural integrity in this trial. For further reading on this development, the full article is available at Bloomberg Law.